SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-18-009305
Filing Date
2018-02-14
Accepted
2018-02-14 06:12:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a18-6122_1sc13da.htm SC 13D/A 43934
2 EX-7.09 a18-6122_1ex7d09.htm EX-7.09 33059
  Complete submission text file 0001104659-18-009305.txt   78650
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 18606848
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filed by) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A